CSIR and National Laboratories — Current Affairs 2026
Current Affairs Connections
CSIR-NCL Develops Advanced Catalysts for Green Hydrogen Production
March 2024CSIR-National Chemical Laboratory (NCL) in Pune recently announced the successful development of novel, highly efficient, and cost-effective catalysts for the electrolysis of water, a critical step in producing green hydrogen. This breakthrough directly supports India's ambitious National Green Hydrogen Mission, aiming to make India a global hub for green hydrogen production and export. The technology promises to reduce the energy input required for electrolysis, thereby lowering the overall cost of green hydrogen. This aligns perfectly with CSIR's Vision 2030 to contribute to strategic national missions and foster sustainable energy solutions, showcasing its role in enabling India's energy transition and achieving net-zero targets. The commercialization of such technologies is crucial for 'Atmanirbhar Bharat'.
UPSC Angle: This development is highly relevant for GS-III (Science & Technology, Environment, Economy). Questions could focus on CSIR's role in the Green Hydrogen Mission, the significance of indigenous catalyst development, or the broader implications for India's energy security and climate goals. It also highlights CSIR's technology transfer potential.
CSIR-CDRI and IGIB Collaborate on AI-driven Drug Discovery Platform for Neglected Diseases
February 2025 (Projected)In a significant inter-laboratory collaboration, CSIR's Central Drug Research Institute (CDRI) and Institute of Genomics and Integrative Biology (IGIB) are projected to launch an AI-driven platform for accelerated drug discovery, specifically targeting neglected tropical diseases prevalent in India. This initiative leverages IGIB's expertise in genomics and bioinformatics with CDRI's drug development capabilities, utilizing artificial intelligence and machine learning to identify potential drug candidates and predict their efficacy more rapidly than traditional methods. This strategic move aligns with CSIR's emphasis on interdisciplinary research and leveraging cutting-edge technologies to address critical health challenges, demonstrating its commitment to public health and innovation in pharmaceuticals. This also links to the broader national push for AI integration in scientific research.
UPSC Angle: This hook is vital for GS-III (Science & Technology, Health). It can lead to questions on the role of AI in drug discovery, inter-institutional collaboration within CSIR, India's efforts to combat neglected diseases, and the future of pharmaceutical research. Aspirants should note the synergy between different CSIR labs and the adoption of advanced technologies.